EORTC


Also found in: Medical, Wikipedia.
AcronymDefinition
EORTCEuropean Organization for Research and Treatment of Cancer
References in periodicals archive ?
SPECTA is a pan-European clinical trial site and cancer patient molecular screening network set up by EORTC in partnership with over 30 prime cancer treatment hubs in 11 European nations to supply efficient availability for patients to molecularly led clinical trials.
Belgium,United States : IGNYTA to partner on STARTRK-2 Phase 2 with EORTC
Michael Weller of the University Hospital Zurich, Chair of the EORTC Brain Tumor Group, and coordinator of this study commented "The EORTC is a leader in enabling multi-disciplinary approaches to investigate strategic therapeutic questions through clinical and translational research.
ImmunoCellular Therapeutics Establishes Agreement with EORTC for ICT-107 Phase 3 Registrational Trial in Glioblastoma
Although common sense favours preservation of kidney function especially with smaller tumours where a significant number are either benign or have less aggressive behaviour, the obsession in achieving ever-higher rates of PN with highly complex tumours in patients with normal renal function may have waned following the publication of the EORTC trial.
Partial versus radical nephrectomy for renal tumours [less than or equal to] 7 cm: the debate continues
The EORTC promotes multidisciplinary cancer research in Europe and is linked to other leading biomedical research organizations around the world.
EMD Serono: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma
Founded in 1962, the EORTC is a nonprofit international cancer research organization under Belgian law.
EORTC, BIG, and Agendia Announce Completion of Patient Recruitment for International MINDACT Study
Andrew Gengos, ImmunoCellular's Chief Executive Officer said, "Working with the EORTC is a key step in our strategy to establish a network of relationships within the clinical oncology community to support the conduct of the ICT-107 Phase 3 trial.
Belgium,United States : IMMUNOCELLULAR secures ICT-107 Phase 3 deal for EORTC
Results: The results obtained with EORTC QLQ-C30 showed significant improvements of several questionnaire-subscales.
Quality of life during mistletoe therapy of cancer patients - An exploratory study with the additional use of questionnaires
The EORTC also assembled a laboratory research team that succeeded in identifying a molecular change in the tumour that predicts benefit from this new therapy.
Breakthrough in Medical Research: New Chemotherapy Gives Hope to Brain Tumour Patients. A Clear Improvement in Survival Demonstrated for Glioblastoma
Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase Ill trial, EORTC Head and Neck Cancer Cooperative Group.
Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer. (Original Article)
To launch the roll-out the project, Alliance Boots held a joint press conference with the EORTC on 14 March in Brussels, in the presence of HRH Princess Astrid (Honorary President of the EORTC Charitable Trust).
Alliance Boots Assisting in the Fight against Cancer: Roll-out of the EORTC Charitable Trust Partnership from April 2012
7%), EORTC QLQ-C30 QOL scales (3/12 = 25%) and symptom scales (2/18 = 11.
Mistletoe and chemotherapy responsiveness of different scalesin oncological patients undergoing chemotherapy
Key recommendations from the new EORTC guidelines that will allow physicians to treat anaemia effectively in their cancer patients include:
New EORTC Cancer Guidelines Focus on Treating Anaemia
Acronyms browser ?
Full browser ?